Sonic Healthcare Limited (ASX:SHL)

Market Cap	13.15B
Revenue (ttm)	9.33B
Net Income (ttm)	545.47M
Shares Out	480.22M
EPS (ttm)	1.14
PE Ratio	24.09
Forward PE	23.07
Dividend	1.06 (3.87%)
Ex-Dividend Date	Mar 5, 2025

Volume	1,228,470
Average Volume	965,102
Open	28.38
Previous Close	28.05
Day's Range	27.26 - 28.41
52-Week Range	23.58 - 29.96
Beta	0.55
RSI	37.69
Earnings Date	Feb 14, 2025

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomograph...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 42,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: SHL

Financial Performance

In 2024, Sonic Healthcare's revenue was 8.97 billion, an increase of 9.77% compared to the previous year's 8.17 billion. Earnings were 511.09 million, a decrease of -25.39%.